• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆酸在TSNO小鼠中iHFC饮食诱导的MASH发展中的关键作用。

Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice.

作者信息

Goto Kana, Kani Koudai, Kato Miyuna, Igarashi Naoya, Tada Yuki, Kasai Kaichi, Ichimura-Shimizu Mayuko, Watanabe Shiro, Tsuneyama Koichi, Furusawa Yukihiro, Nagai Yoshinori

机构信息

Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Department of Pathology and Laboratory Medicine, Tokushima University Graduate School of Biomedical Sciences, 3-8-15 Kuramoto-Cho, Tokushima, 770-8503, Japan.

出版信息

Inflammation. 2025 Jun 9. doi: 10.1007/s10753-025-02294-5.

DOI:10.1007/s10753-025-02294-5
PMID:40490659
Abstract

A high-fat/cholesterol/cholate-based (iHFC) diet induces pathological changes in Tsumura-Suzuki non-obese (TSNO) mice, resembling human metabolic dysfunction associated steatohepatitis (MASH), along with advanced liver fibrosis. In this study, we investigated the role of cholic acid (CA) in the development of iHFC diet-induced MASH development. In mice receiving an iHFC diet without CA (CA(-) iHFC diet), both lobular inflammation and fibrosis progression in the liver were attenuated compared to those on the standard iHFC diet. Notably, hepatocyte ballooning was significantly improved in the CA(-) iHFC diet group. The expression levels of genes associated with inflammation and fibrosis were lower in the livers of CA(-) iHFC diet-fed mice compared to those fed the iHFC diet. Furthermore, there were no significant changes in the proportion and number of monocyte-derived macrophages in the livers of CA(-) iHFC diet-fed mice relative to those in the ND (normal diet)-fed group. The co-localization of CD11c macrophages with collagen fibers in the livers of CA(-) iHFC diet-fed mice did not significantly differ from that of the ND-fed group. Moreover, the CA(-) iHFC-fed mice exhibited a distinct microbial composition relative to both ND- and iHFC-fed mice. Finally, the increase in deoxycholic acid in fecal samples and the reduced hepatic expression of Cyp27a1 and Cyp7a1 induced by the iHFC diet were less in the CA(-) iHFC-fed group. These results suggest that CA modulates iHFC diet-induced MASH development by influencing the accumulation of monocyte-derived macrophages in the liver and shaping the gut microbiota composition and bile acid profile.

摘要

基于高脂肪/胆固醇/胆酸盐的(iHFC)饮食会在津村-铃木非肥胖(TSNO)小鼠中诱发病理变化,类似于人类代谢功能障碍相关脂肪性肝炎(MASH),并伴有晚期肝纤维化。在本研究中,我们调查了胆酸(CA)在iHFC饮食诱导的MASH发展中的作用。在接受不含CA的iHFC饮食(CA(-) iHFC饮食)的小鼠中,与标准iHFC饮食组相比,肝脏中的小叶炎症和纤维化进展均有所减轻。值得注意的是,CA(-) iHFC饮食组的肝细胞气球样变得到了显著改善。与喂食iHFC饮食的小鼠相比,喂食CA(-) iHFC饮食的小鼠肝脏中与炎症和纤维化相关的基因表达水平较低。此外,相对于喂食正常饮食(ND)的组,喂食CA(-) iHFC饮食的小鼠肝脏中单核细胞衍生巨噬细胞的比例和数量没有显著变化。喂食CA(-) iHFC饮食的小鼠肝脏中CD11c巨噬细胞与胶原纤维的共定位与喂食ND的组没有显著差异。此外,相对于喂食ND和iHFC的小鼠,喂食CA(-) iHFC的小鼠表现出独特的微生物组成。最后,CA(-) iHFC喂食组粪便样本中脱氧胆酸的增加以及iHFC饮食诱导的肝脏中Cyp27a1和Cyp7a1表达的降低较少。这些结果表明,CA通过影响单核细胞衍生巨噬细胞在肝脏中的积累以及塑造肠道微生物群组成和胆汁酸谱来调节iHFC饮食诱导的MASH发展。

相似文献

1
Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice.胆酸在TSNO小鼠中iHFC饮食诱导的MASH发展中的关键作用。
Inflammation. 2025 Jun 9. doi: 10.1007/s10753-025-02294-5.
2
Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice.肝巨噬细胞、肠道微生物群和胆汁酸代谢对 TSNO 和 TSOD 小鼠在 iHFC 饮食诱导的 MASH 进展差异的影响。
Inflamm Res. 2024 Jul;73(7):1081-1098. doi: 10.1007/s00011-024-01884-7. Epub 2024 Apr 15.
3
Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.万古霉素治疗和肠道微生物群对胆汁酸代谢和小鼠非酒精性脂肪性肝炎发展的影响。
Int J Mol Sci. 2023 Feb 17;24(4):4050. doi: 10.3390/ijms24044050.
4
Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice.使用C57BL/6小鼠的非酒精性脂肪性肝炎新型小鼠模型中肝脏巨噬细胞亚群的动态变化
Biomedicines. 2023 Sep 28;11(10):2659. doi: 10.3390/biomedicines11102659.
5
Antibiotic effects on gut microbiota modulate diet-induced metabolic dysfunction-associated steatohepatitis development in C57BL/6 mice.抗生素对肠道微生物群的影响调节了C57BL/6小鼠饮食诱导的代谢功能障碍相关脂肪性肝炎的发展。
Genes Cells. 2024 Aug;29(8):635-649. doi: 10.1111/gtc.13134. Epub 2024 Jun 12.
6
Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis.建立一种新型的饮食诱导的非酒精性脂肪性肝炎相关进展性桥接纤维化的小鼠模型。
Biosci Biotechnol Biochem. 2021 Mar 24;85(4):941-947. doi: 10.1093/bbb/zbaa107.
7
Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating aryl hydrocarbon receptor-dependent AMPK signaling.朱红酸通过激活芳烃受体依赖性AMPK信号通路预防代谢功能障碍相关脂肪性肝炎。
Am J Physiol Gastrointest Liver Physiol. 2025 Apr 1;328(4):G433-G447. doi: 10.1152/ajpgi.00337.2024. Epub 2025 Mar 10.
8
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.胆汁酸会促使小鼠发生非酒精性脂肪性肝炎。
JHEP Rep. 2021 Oct 13;4(1):100387. doi: 10.1016/j.jhepr.2021.100387. eCollection 2022 Jan.
9
Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.膳食脂肪和肠道微生物群的相互作用决定了小鼠的饮食诱导肥胖。
Mol Metab. 2016 Oct 13;5(12):1162-1174. doi: 10.1016/j.molmet.2016.10.001. eCollection 2016 Dec.
10
Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice.抑制脂肪甘油三酯脂肪酶(ATGL)可通过损害过氧化物酶体增殖物激活受体α(PPARα)信号通路来减轻小鼠的巨噬细胞活化综合征(MASH),该信号通路有利于亲水性胆汁酸组成。
J Hepatol. 2025 Apr;82(4):658-675. doi: 10.1016/j.jhep.2024.09.037. Epub 2024 Sep 30.

本文引用的文献

1
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.MASH 中的免疫动力学:从景观分析到治疗干预。
J Gastroenterol. 2024 Dec;59(12):1053-1078. doi: 10.1007/s00535-024-02157-0. Epub 2024 Oct 14.
2
Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH.由NCF1调控的活性氧物种决定了库普弗细胞对MASH的铁死亡易感性。
Cell Metab. 2024 Aug 6;36(8):1745-1763.e6. doi: 10.1016/j.cmet.2024.05.008. Epub 2024 Jun 7.
3
Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice.
肝巨噬细胞、肠道微生物群和胆汁酸代谢对 TSNO 和 TSOD 小鼠在 iHFC 饮食诱导的 MASH 进展差异的影响。
Inflamm Res. 2024 Jul;73(7):1081-1098. doi: 10.1007/s00011-024-01884-7. Epub 2024 Apr 15.
4
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.NASH 的抗炎和抗纤维化治疗靶点的综合观点。
J Hepatol. 2023 Aug;79(2):552-566. doi: 10.1016/j.jhep.2023.03.038. Epub 2023 Apr 14.
5
Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.万古霉素治疗和肠道微生物群对胆汁酸代谢和小鼠非酒精性脂肪性肝炎发展的影响。
Int J Mol Sci. 2023 Feb 17;24(4):4050. doi: 10.3390/ijms24044050.
6
Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis.利用新建立的饮食诱导非酒精性脂肪性肝炎小鼠模型鉴定巨噬细胞在晚期肝纤维化中的作用。
Int J Mol Sci. 2022 Oct 31;23(21):13251. doi: 10.3390/ijms232113251.
7
Nuclear receptors in liver fibrosis.核受体在肝纤维化中的作用。
Biochim Biophys Acta Mol Basis Dis. 2021 Dec 1;1867(12):166235. doi: 10.1016/j.bbadis.2021.166235. Epub 2021 Jul 31.
8
Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis.建立一种新型的饮食诱导的非酒精性脂肪性肝炎相关进展性桥接纤维化的小鼠模型。
Biosci Biotechnol Biochem. 2021 Mar 24;85(4):941-947. doi: 10.1093/bbb/zbaa107.
9
Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH.动态变化的驻留巨噬细胞和募集巨噬细胞组成影响 NASH 组织重塑。
Cell Rep. 2021 Jan 12;34(2):108626. doi: 10.1016/j.celrep.2020.108626.
10
Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver.骨桥蛋白表达鉴定了肝脂肪变性中招募的巨噬细胞亚群,与枯否细胞不同。
Immunity. 2020 Sep 15;53(3):641-657.e14. doi: 10.1016/j.immuni.2020.08.004. Epub 2020 Sep 3.